Understanding Rad54L2: Potential Drug Targets Or Biomarkers for Various Diseases

Target Name: RAD54L2

NCBI ID: G23132

RAD54L2

Understanding Rad54L2: Potential Drug Targets Or Biomarkers for Various Diseases

Rad54L2, also known as RAD54-like protein 2, is a protein that is expressed in various tissues and cells throughout the body. It is a key component of the DNA replication and repair process, and has been shown to play a crucial role in the regulation of gene expression and DNA stability.

Recent studies have suggested that Rad54L2 may have potential as a drug target or biomarker for a variety of diseases. In this article, we will explore the biology and potential therapeutic applications of Rad54L2.

The biology of Rad54L2

Rad54L2 is a member of the Rad54 family of proteins, which are involved in the regulation of DNA replication and repair. These proteins are named after the cytoskeleton protein actinin, which is composed of the protein Rad54. The Rad54 family includes six proteins: Rad54, Rad54-like protein 1 (RPL1), Rad54-like protein 2 (RPL2), Rad54-like protein 3 (RPL3), Rad54-like protein 4 (RPL4), and Rad54-like protein 5 (RPL5).

Rad54L2 is a 21 kDa protein that is expressed in various tissues and cells throughout the body. It is predominantly expressed in the nuclei of eukaryotic cells, and is also found in the cytoplasm of these cells. Rad54L2 is involved in the regulation of DNA replication and repair, and has been shown to play a crucial role in the regulation of gene expression and DNA stability.

Potential therapeutic applications of Rad54L2

Rad54L2 has been suggested as a potential drug target or biomarker for a variety of diseases. One potential therapeutic application of Rad54L2 is in the treatment of cancer. Rad54L2 has been shown to play a role in the regulation of cell cycle progression, and has been shown to be involved in the development of cancer. Therefore, targeting Rad54L2 with drugs that inhibit its activity may be a promising strategy for the treatment of cancer.

Another therapeutic potential application of Rad54L2 is in the treatment of neurodegenerative diseases. Rad54L2 has been shown to play a role in the regulation of cellular stress responses, and has been implicated in the development of neurodegenerative diseases. Therefore, targeting Rad54L2 with drugs that modulate its activity may be a promising strategy for the treatment of neurodegenerative diseases.

Rad54L2 has also been suggested as a potential biomarker for a variety of diseases. The level of Rad54L2 expression in tissues and cells can be increased by various means, such as overexpression or knockdown. This can be used to study the role of Rad54L2 in disease development and progression. Therefore, measuring the level of Rad54L2 expression in tissues and cells may be a useful tool for the diagnosis and prognosis of various diseases.

Conclusion

Rad54L2 is a protein that is involved in the regulation of DNA replication and repair and has been shown to play a crucial role in the regulation of gene expression and DNA stability. Its potential as a drug target or biomarker for a variety of diseases makes it an promising target for future research. Further studies are needed to fully understand the role of Rad54L2 in disease development and progression.

Protein Name: RAD54 Like 2

Functions: DNA helicase that modulates androgen receptor (AR)-dependent transactivation in a promoter-dependent manner. Not able to remodel mononucleosomes in vitro (By similarity)

The "RAD54L2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RAD54L2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets